Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Language
Publication year range
1.
Nat Nanotechnol ; 12(4): 378-386, 2017 05.
Article in English | MEDLINE | ID: mdl-28068318

ABSTRACT

A material that rapidly absorbs molecular oxygen (known as an oxygen scavenger or deoxygenation agent (DOA)) has various industrial applications, such as in food preservation, anticorrosion of metal and coal deoxidation. Given that oxygen is vital to cancer growth, to starve tumours through the consumption of intratumoral oxygen is a potentially useful strategy in fighting cancer. Here we show that an injectable polymer-modified magnesium silicide (Mg2Si) nanoparticle can act as a DOA by scavenging oxygen in tumours and form by-products that block tumour capillaries from being reoxygenated. The nanoparticles are prepared by a self-propagating high-temperature synthesis strategy. In the acidic tumour microenvironment, the Mg2Si releases silane, which efficiently reacts with both tissue-dissolved and haemoglobin-bound oxygen to form silicon oxide (SiO2) aggregates. This in situ formation of SiO2 blocks the tumour blood capillaries and prevents tumours from receiving new supplies of oxygen and nutrients.


Subject(s)
Magnesium , Nanoparticles , Neoplasms , Neovascularization, Pathologic , Oxygen/metabolism , Silicon Compounds , Animals , Bisphenol A-Glycidyl Methacrylate/pharmacokinetics , HeLa Cells , Humans , MCF-7 Cells , Magnesium/chemistry , Magnesium/pharmacokinetics , Magnesium/pharmacology , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Neoplasms/blood supply , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Rats , Silicon Compounds/chemistry , Silicon Compounds/pharmacokinetics , Silicon Compounds/pharmacology
2.
An Bras Dermatol ; 91(3): 331-5, 2016.
Article in English | MEDLINE | ID: mdl-27438201

ABSTRACT

Silicon is the second most abundant element on Earth, and the third most abundant trace element in human body. It is present in water, plant and animal sources. On the skin, it is suggested that silicon is important for optimal collagen synthesis and activation of hydroxylating enzymes, improving skin strength and elasticity. Regarding hair benefits, it was suggested that a higher silicon content in the hair results in a lower rate of hair loss and increased brightness. For these beneficial effects, there is growing interest in scientific studies evaluating the efficacy and safety of using dietary supplements containing silicon. Its use aims at increasing blood levels of this element and improving the skin and its annexes appearance. There are different forms of silicon supplements available and the most important consideration to be made in order to select the best option is related to safety and bioavailability. Silicon supplements are widely used, though there is wide variation in silicon bioavailability, ranging from values below 1% up to values close to 50%, depending on the chemical form. Therefore, the aim of this study was to evaluate the scientific literature related to the different chemical forms of silicon supplements available and the limitations and recent progress in this field. According to reported studies, among the different chemical forms available, the orthosilicic acid (OSA) presents the higher bioavailability, whereas the others forms have absorption inversely proportional to the degree of polymerization. However, clinical studies evaluating safety and efficacy are still lacking.


Subject(s)
Hair Diseases , Silicic Acid/pharmacokinetics , Silicon/pharmacokinetics , Skin Aging/drug effects , Biological Availability , Collagen/biosynthesis , Dietary Supplements , Hair Diseases/drug therapy , Humans , Nail Diseases/drug therapy , Silicic Acid/therapeutic use , Silicon/deficiency , Silicon/physiology , Silicon/therapeutic use , Silicon Compounds/pharmacokinetics , Silicon Compounds/therapeutic use , Skin Aging/physiology
3.
An. bras. dermatol ; 91(3): 331-335,
Article in English | LILACS | ID: lil-787284

ABSTRACT

Abstract Silicon is the second most abundant element on Earth, and the third most abundant trace element in human body. It is present in water, plant and animal sources. On the skin, it is suggested that silicon is important for optimal collagen synthesis and activation of hydroxylating enzymes, improving skin strength and elasticity. Regarding hair benefits, it was suggested that a higher silicon content in the hair results in a lower rate of hair loss and increased brightness. For these beneficial effects, there is growing interest in scientific studies evaluating the efficacy and safety of using dietary supplements containing silicon. Its use aims at increasing blood levels of this element and improving the skin and its annexes appearance. There are different forms of silicon supplements available and the most important consideration to be made in order to select the best option is related to safety and bioavailability. Silicon supplements are widely used, though there is wide variation in silicon bioavailability, ranging from values below 1% up to values close to 50%, depending on the chemical form. Therefore, the aim of this study was to evaluate the scientific literature related to the different chemical forms of silicon supplements available and the limitations and recent progress in this field. According to reported studies, among the different chemical forms available, the orthosilicic acid (OSA) presents the higher bioavailability, whereas the others forms have absorption inversely proportional to the degree of polymerization. However, clinical studies evaluating safety and efficacy are still lacking.


Subject(s)
Humans , Silicic Acid/pharmacokinetics , Silicon/pharmacokinetics , Skin Aging/drug effects , Hair Diseases , Silicic Acid/therapeutic use , Silicon/deficiency , Silicon/physiology , Silicon/therapeutic use , Biological Availability , Skin Aging/physiology , Collagen/biosynthesis , Silicon Compounds/therapeutic use , Silicon Compounds/pharmacokinetics , Dietary Supplements , Hair Diseases/drug therapy , Nail Diseases/drug therapy
4.
Invest Ophthalmol Vis Sci ; 54(2): 1268-79, 2013 Feb 01.
Article in English | MEDLINE | ID: mdl-23322571

ABSTRACT

PURPOSE: To test the feasibility of covalent loading of daunorubicin into oxidized porous silicon (OPS) and to evaluate the ocular properties of sustained delivery of daunorubicin in this system. METHODS: Porous silicon was heat oxidized and chemically functionalized so that the functional linker on the surface was covalently bonded with daunorubicin. The drug loading rate was determined by thermogravimetric analysis. Release of daunorubicin was confirmed in PBS and excised rabbit vitreous by mass spectrometry. Daunorubicin-loaded OPS particles (3 mg) were intravitreally injected into six rabbits, and ocular properties were evaluated through ophthalmic examinations and histology during a 3-month study. The same OPS was loaded with daunorubicin using physical adsorption and was evaluated similarly as a control for the covalent loading. RESULTS: In the case of covalent loading, 67 ± 10 µg daunorubicin was loaded into each milligram of the particles while 27 ± 10 µg/mg particles were loaded by physical adsorption. Rapid release of daunorubicin was observed in both PBS and excised vitreous (~75% and ~18%) from the physical adsorption loading, while less than 1% was released from the covalently loaded particles. Following intravitreal injection, the covalently loaded particles demonstrated a sustained degradation of OPS with drug release for 3 months without evidence of toxicity; physical adsorption loading revealed a complete release within 2 weeks and localized retinal toxicity due to high daunorubicin concentration. CONCLUSIONS: OPS with covalently loaded daunorubicin demonstrated sustained intravitreal drug release without ocular toxicity, which may be useful to inhibit unwanted intraocular proliferation.


Subject(s)
Antibiotics, Antineoplastic/pharmacokinetics , Daunorubicin/pharmacokinetics , Drug Delivery Systems/methods , Retina/drug effects , Silicon Compounds/pharmacokinetics , Vitreous Body/drug effects , Animals , Antibiotics, Antineoplastic/toxicity , Apoptosis/drug effects , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacokinetics , Biocompatible Materials/toxicity , Daunorubicin/toxicity , Drug Combinations , Intravitreal Injections , Oxidation-Reduction , Porosity , Rabbits , Retina/cytology , Retina/metabolism , Silicon Compounds/chemistry , Silicon Compounds/toxicity , Spectrometry, Mass, Electrospray Ionization , Vitreous Body/metabolism
5.
Toxicol Appl Pharmacol ; 264(2): 232-45, 2012 Oct 15.
Article in English | MEDLINE | ID: mdl-22981607

ABSTRACT

BACKGROUND: Silicon carbide (SiC) presents noteworthy properties as a material such as high hardness, thermal stability, and photoluminescent properties as a nanocrystal. However, there are very few studies in regard to the toxicological potential of SiC NPs. OBJECTIVES: To study the toxicity and biodistribution of silicon carbide (SiC) nanoparticles in an in vivo rat model after acute (24h) and subacute (28days) oral administrations. The acute doses were 0.5, 5, 50, 300 and 600mg·kg(-1), while the subacute doses were 0.5 and 50mg·kg(-1). RESULTS: SiC biodistribution and elemental composition of feces and organs (liver, kidneys, and spleen) have been studied by Particle-Induced X-ray Emission (PIXE). SiC and other elements in feces excretion increased by the end of the subacute assessment. SiC did not accumulate in organs but some elemental composition modifications were observed after the acute assessment. Histopathological sections from organs (stomach, intestines, liver, and kidneys) indicate the absence of damage at all applied doses, in both assessments. A decrease in the concentration of urea in blood was found in the 50mg·kg(-1) group from the subacute assessment. No alterations in the urine parameters (sodium, potassium, osmolarity) were found. CONCLUSION: This is the first study that assesses the toxicity, biodistribution, and composition changes in feces and organs of SiC nanoparticles in an in vivo rat model. SiC was excreted mostly in feces and low traces were retrieved in urine, indicating that SiC can cross the intestinal barrier. No sign of toxicity was however found after oral administration.


Subject(s)
Biocompatible Materials/pharmacokinetics , Biocompatible Materials/toxicity , Carbon Compounds, Inorganic/pharmacokinetics , Carbon Compounds, Inorganic/toxicity , Feces/chemistry , Nanoparticles/toxicity , Silicon Compounds/pharmacokinetics , Silicon Compounds/toxicity , Animal Feed/analysis , Animals , Elements , Female , Granuloma/chemically induced , Granuloma/pathology , Microscopy, Electron, Transmission , Particle Size , Photoelectron Spectroscopy , Rats , Rats, Sprague-Dawley , Spectrometry, X-Ray Emission , Tissue Distribution
6.
Nanotoxicology ; 6(3): 263-71, 2012 May.
Article in English | MEDLINE | ID: mdl-21504370

ABSTRACT

With the advent of nanoparticles produced in high quantities and employed in products or processes, the need to evaluate their potential toxicological effects is necessary. For this purpose, biopersistence studies are needed to assess the possible effects of nanoparticles in parallel with a proper characterization. The insoluble character of many nanomaterials makes traditional chemical analytical methods unapplicable for the ex-vivo measurements of their concentration in organs. Ion beam-based techniques such as Particle-Induced X-ray Emission (PIXE) can solve this difficulty. We illustrate that by the measurement of biopersistence of SiC and TiC nanoparticles instilled in rats lungs and investigated over a 60-day time span. The results can be obtained within minutes and the limits of detection are within ppm levels.


Subject(s)
Carbon Compounds, Inorganic/analysis , Lung/metabolism , Nanoparticles/analysis , Silicon Compounds/analysis , Spectrometry, X-Ray Emission/methods , Titanium/analysis , Animals , Carbon Compounds, Inorganic/administration & dosage , Carbon Compounds, Inorganic/pharmacokinetics , Equipment Design , Female , Instillation, Drug , Microscopy, Electron, Transmission , Nanoparticles/administration & dosage , Nanoparticles/ultrastructure , Particle Size , Rats , Rats, Wistar , Silicon Compounds/administration & dosage , Silicon Compounds/pharmacokinetics , Solubility , Surface Properties , Tissue Distribution , Titanium/administration & dosage , Titanium/pharmacokinetics
7.
Chem Commun (Camb) ; 46(18): 3188-90, 2010 May 14.
Article in English | MEDLINE | ID: mdl-20424769

ABSTRACT

A novel tetraamino silicon(iv) phthalocyanine has been prepared, of which the fluorescence emission and reactive oxygen species generation efficiency are greatly enhanced at lower pH in the range of ca. 5-7, making it a promising pH-controlled and tumour-selective fluorescence probe and photosensitiser for photodynamic therapy.


Subject(s)
Fluorescent Dyes/chemistry , Indoles/chemistry , Neoplasms/drug therapy , Photosensitizing Agents/chemistry , Silicon Compounds/chemistry , Amines/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Fluorescent Dyes/pharmacokinetics , Fluorescent Dyes/pharmacology , Humans , Hydrogen-Ion Concentration , Indoles/pharmacokinetics , Indoles/pharmacology , Isoindoles , Liver Neoplasms/drug therapy , Photochemotherapy , Photosensitizing Agents/pharmacokinetics , Photosensitizing Agents/pharmacology , Reactive Oxygen Species/metabolism , Silicon Compounds/pharmacokinetics , Silicon Compounds/pharmacology
8.
Inhal Toxicol ; 19(2): 141-7, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17169861

ABSTRACT

Silicon carbide whisker (SiCW) is a durable asbestos substitute. To clarify the biopersistence, the changes of geometrical configurations of deposited whiskers, and potential carcinogenicity and fibrogenicity, 42 Wistar male rats were exposed to SiCW for 6 h/day, 5 days/wk for 1 yr by inhalation. The mass median aerodynamic diameter (geometric standard deviation, GSD), the geometric mean fiber diameter (GSD), and the geometric mean fiber length (GSD) were 2.4 microm (2.4), 0.5 microm (1.5) and 2.8 microm (2.3), respectively. The daily average exposure concentrations were 2.6 +/- 0.4 mg/m3 (98 +/- 19 fibers/ml) and the rats were sacrificed at 6 days and 3, 6, and 12 mo after the exposure. The SiCW amount deposited in each rat lung at 6 days after the exposure, determined by an x-ray diffraction method, was 5.3 +/- 1.4 mg. The biological half-time (BHT) was 16 mo calculated from the deposited SiCW at 6 days and 3, 6, and 12 mo. The BHT was more prolonged than normal physiological clearance. The diameter of SiCW in the lung at each sacrificed time during 12 mo of clearance after the inhalation did not change. However, as for the length of SiCW in the lung, longer SiCW tended to be retained in the lung as the clearance time increased, especially after 6 mo. The histopathological examination revealed bronchoalveolar hyperplasia (BAH) in 2 rats at 1 yr after the exposure and severe fibrotic changes around aggregated SiCW.


Subject(s)
Bronchi/drug effects , Carbon Compounds, Inorganic/toxicity , Pulmonary Alveoli/drug effects , Silicon Compounds/toxicity , Administration, Inhalation , Animals , Body Weight/drug effects , Bronchi/metabolism , Bronchi/pathology , Carbon Compounds, Inorganic/pharmacokinetics , Hyperplasia/chemically induced , Hyperplasia/metabolism , Hyperplasia/pathology , Longevity/drug effects , Lung/drug effects , Lung/pathology , Male , Mineral Fibers/toxicity , Organ Size/drug effects , Particle Size , Pulmonary Alveoli/metabolism , Pulmonary Alveoli/pathology , Rats , Rats, Wistar , Silicon Compounds/pharmacokinetics , X-Ray Diffraction
9.
Br J Ind Med ; 50(9): 797-806, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8398873

ABSTRACT

The question of lung damage as a result of exposure to silicon carbide (SiC) was investigated by inhalation experiments to obtain information on the qualitative response of lung tissue to the test substance (SiC). For comparison, quartz, kaolinite, and tempered clay dusts were used. The indices for the effects of the dusts studied were organ weights, numbers of bronchoalveolar cells, lung surfactant phospholipid concentrations including subfractions, and lung clearance. Exposure to the test samples was carried out according to the Essen inhalation model in two independent series. The results of the two series were similar: Compared with sham controls, exposure to SiC did not affect the indices studied. Even at a low dose (a quarter of the SiC dose) quartz gave pronounced deviations in all indices. In particular, an increase in granulocytes indicated toxic properties of the dust. The long term elimination of quartz from the lung was worse than that of SiC. The kaolinite and tempered clay dusts were intermediate between SiC and quartz based on several of the indices studied. It is concluded that SiC is deposited practically inert in the lung.


Subject(s)
Carbon Compounds, Inorganic , Carbon/toxicity , Dust/adverse effects , Lung/drug effects , Silicon Compounds/toxicity , Administration, Inhalation , Animals , Bronchoalveolar Lavage Fluid/cytology , Carbon/pharmacokinetics , Cell Count/drug effects , Female , Lung/metabolism , Lymph Nodes/pathology , Mediastinum , Organ Size/drug effects , Pulmonary Surfactants/metabolism , Rats , Rats, Wistar , Silicon Compounds/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...